Haaaaa haaa haaaaaa haaaaaa haaaaa...... the net proceeds of the Recapitalisation would be used to settle all or part of BioAmber’s outstanding obligations. I guess they have some shares to sell in the transaction... maybe 100 million worth or so? the missing 25 million at a 4.17????????